Market revenue in 2023 | USD 973.4 million |
Market revenue in 2030 | USD 1,472.4 million |
Growth rate | 6.1% (CAGR from 2023 to 2030) |
Largest segment | Monitors |
Fastest growing segment | Sensors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Monitors, Sensors |
Key market players worldwide | Medtronic PLC, Masimo Corp, Koninklijke Philips NV, GE Aerospace, Nonin Medical, Nihon Kohden Corp, ICU Medical Inc, OSI Systems Inc, CONTEC, Draegerwerk AG & Co KGaA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pulse oximeter market will help companies and investors design strategic landscapes.
Monitors was the largest segment with a revenue share of 64.78% in 2023. Horizon Databook has segmented the U.S. pulse oximeter market based on monitors, sensors covering the revenue growth of each sub-segment from 2018 to 2030.
There is a high prevalence of CHD in the U.S. and it is one of the most common birth defects observed. Prenatal testing by ultrasound detects only 23% of unborn infant defects, out of which, 11% result in live births. Postnatal detection can aid in saving lives of almost 50% of cases, whereas other cases are noticed after showing CCHD symptoms.
This life-threatening disease accounts for almost 30% of infant deaths; around 7,200 infants are born with CCHD annually. Pulse oximeter screening can aid in detecting problems and avoiding risk of serious complications in the first few weeks of an infant’s life.
The use of pulse oximetry has been mandated for screening newborns before they are discharged from a healthcare setting. Since 2011, the American Academy of Pediatrics (AAP) has recommended pulse oximetry to be a part of newborn screening for the detection of CCHD, which was implemented by 2014.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pulse oximeter market , including forecasts for subscribers. This country databook contains high-level insights into U.S. pulse oximeter market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account